Company intelligence / Profile preview
AntiCancer
San Diego, California, United Statesanticancer.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
No late-stage clinical trial results reported. The PDOX mouse model has demonstrated high clinical concordance with human tumor behavior and is used by major pharma/biotech companies for drug discovery. The methionine restriction approach has shown promise in preclinical studies across all tested cancers.
- Therapeutic areas
- Oncology
- Modalities
- ProteinMouse model technology
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
collaborations with major biotechnology companies for furthering research into methionine restriction therapies and commercialization of PDOX models
Beyond the preview
Go deeper on AntiCancer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AntiCancer.